These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 300795)

  • 1. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mixed connective tissue disease (Sharp's syndrome)].
    Müller W; Rosenthal M
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():744-50. PubMed ID: 306173
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of patients with serum antibodies to extractable nuclear antigens.
    Leibfarth JH; Persellin RH
    Arthritis Rheum; 1976; 19(5):851-6. PubMed ID: 786296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML; Dawkins B; Dawkins RL; Owen ET
    Ann Rheum Dis; 1979 Feb; 38(1):74-8. PubMed ID: 312058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed connective tissue disease.
    Minkin W; Rabhan N
    Arch Dermatol; 1976 Nov; 112(11):1535-8. PubMed ID: 1086651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J
    Scand J Rheumatol; 1976; 5(3):177-83. PubMed ID: 790556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of antinuclear antibodies in systemic rheumatic diseases.
    Notman DD; Kurata N; Tan EM
    Ann Intern Med; 1975 Oct; 83(4):464-9. PubMed ID: 1080976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP; Gaudreau A; Amor B; Kahn MF; Ryckewaert A; Sany J; Haim T
    Nouv Presse Med; 1978 May; 7(21):1813-8. PubMed ID: 307737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the complement-fixing activity of antinuclear antibodies in lupus nephritis, mixed connective tissue disease, and scleroderma.
    Parker MD; Turner RA
    Arthritis Rheum; 1976; 19(5):857-61. PubMed ID: 786297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis.
    Bresnihan B; Bunn C; Snaith ML; Hughes GR
    Br Med J; 1977 Mar; 1(6061):610-1. PubMed ID: 843832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
    Grennan DM; Bunn C; Hughes GR; Buchanan WW; Dick WC
    Ann Rheum Dis; 1977 Oct; 36(5):442-7. PubMed ID: 921344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
    Kahn MF; Peltier AP; Appelboom T
    Nouv Presse Med; 1975 Jun; 4(25):1863-5. PubMed ID: 1080278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T; Kahn MF; Peltier AP; de SEZE S
    Ann Med Interne (Paris); 1974 Nov; 125(11):841-8. PubMed ID: 4218716
    [No Abstract]   [Full Text] [Related]  

  • 18. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 19. Mixed connective tissue disease in childhood. Relationship Sjögren's syndrome.
    Fraga A; Gudiño J; Ramos-Niembro F; Aiarcón-Segovia D
    Am J Dis Child; 1978 Mar; 132(3):263-5. PubMed ID: 629242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.